All In Biotech

Drug Trial Radar · NCT01256762

Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer

A Randomized Phase II Study Of Imetelstat (GRN163L) In Combination With Paclitaxel (With Or Without Bevacizumab) in Patients With Locally Recurrent Or Metastatic Breast Cancer

Last checked: Nov 19, 2026Latest source record: Jan 26, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 166 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

166

Actual

Start

Nov 2010

Primary completion

Oct 2012

Study completion Dec 2012

Sponsor

Lead sponsor
Geron CorporationIndustry
Sponsor type
Industry
First posted
Dec 9, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy and safety of treatment with imetelstat + paclitaxel (with or without bevacizumab) versus paclitaxel (with or without bevacizumab) alone for patients with locally recurrent or metastatic breast cancer who have not received chemotherapy or have received one non-taxane based chemotherapy for metastatic breast cancer.

Conditions

  • Locally Recurrent or Metastatic Breast Cancer

Interventions

  • Imetelstat sodiumDrug

    Imetelstat is administered at a dose of 300 mg/m2 on day one of a 21 day cycle.

  • BevacizumabDrug

    Bevacizumab is administered at 15 mg/kg on day one of a 21 day cycle

  • PaclitaxelDrug

    Paclitaxel is administered at 90 mg/m2 on days one and eight of a 21 day cycle

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression-free survivalTime frame: Occurring post randomization through end of study period (9 mos. after the last participant is randomized)

Locations

55 sites in 2 countries. Site status is shown where the registry gives one.

  • Clearview Cancer Center

    Huntsville, Alabama

  • Alta Bates Summit Medical Center

    Berkeley, California

  • Southbay Oncology Hematology Partners

    Campbell, California

  • Cancer Care Associates

    Fresno, California

  • Memorial Miller Hospital

    Long Beach, California

  • St. Joseph Hospital

    Orange, California

  • Desert Regional Comprehensive Cancer Center

    Palm Springs, California

  • UC San Diego

    San Diego, California

  • Redwood Regional Medical Group

    Santa Rosa, California

  • Univ. Colorado at Denver

    Aurora, Colorado

  • Connecticut Oncology & Hematology

    Torrington, Connecticut

  • Medical Oncology Hematology

    Waterbury, Connecticut

  • Florida Oncology Associates

    Jacksonville, Florida

  • Hematology Oncology Associates

    Port Saint Lucie, Florida

  • H. Lee Moffitt Cancer Center

    Tampa, Florida

  • Northeast Georgia Cancer Care

    Athens, Georgia

  • Peachtree Hematology Oncology

    Atlanta, Georgia

  • Emory University

    Atlanta, Georgia

  • Northeast Georgia Medical Center

    Gainesville, Georgia

  • Central Georgia Cancer Care

    Macon, Georgia

  • Summit Cancer Care

    Savannah, Georgia

  • Kootenai Medical Center

    Post Falls, Idaho

  • Ingalls Memorial Hospital

    Chicago, Illinois

  • Rush University

    Chicago, Illinois

  • Mid Illinois Hematology & Oncology

    Normal, Illinois

  • Cancer Treatment Centers of America

    Zion, Illinois

  • Indiana University

    Indianapolis, Indiana

  • Community Hospitals of Indiana

    Indianapolis, Indiana

  • Horizon Oncology Center

    Lafayette, Indiana

  • Cancer Center of Kansas

    Wichita, Kansas

  • Montgomery Cancer Care

    Mount Sterling, Kentucky

  • Michigan State University

    East Lansing, Michigan

  • New Mexico Cancer Center

    Albuquerque, New Mexico

  • Prohealth Associates

    Lake Success, New York

  • Stony Brook University

    Stony Brook, New York

  • Carolinas Hematology/Oncology

    Charlotte, North Carolina

  • Moses Cone Medical System

    Greensboro, North Carolina

  • Case Western Reserve Univ.

    Cleveland, Ohio

  • Mercy Physicians of Oklahoma

    Oklahoma City, Oklahoma

  • Cancer Care Associates

    Tulsa, Oklahoma

Showing 40 of 55 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.